Newswise — TAMPA, Fla. — Moffitt Cancer Center has been awarded a four-year, $3 million grant from the Department of Defense’s Congressionally Directed Medical Research Programs to develop new treatments for rare melanomas, including uveal melanoma. The grant will fund two projects aimed at advancing targeted alpha-particle therapies.
Latest News
Melanoma: causes, identification and diagnosis
The British broadcaster and DJ, Chris Evans, has revealed that he has been diagnosed with a skin cancer called a “melanoma”. The 57-year-old says that he was tested for the disease after his masseuse noticed a mark on his shin. So, what exactly is melanoma? Julia Newton-Bishop is a professor of dermatology at the University of Leeds…
A drug for heart conditions improves efficacy of melanoma therapies
A collaborative study undertaken by the Navarrabiomed Biomedical Research Center (Pamplona, ??Navarre), the Institute of Neurosciences CSIC-UMH (Sant Joan d’Alacant, Valencian Community) and IRB Barcelona (Barcelona, ??Catalonia) shows that the administration of ranolazine, a drug currently used to treat heart conditions, improves the efficacy of current therapies for melanoma, in mouse models of this disease.
Skin cancer screening guidelines can seem confusing – three skin cancer researchers explain when to consider getting checked
Protecting oneself from the summer sun and its damaging ultraviolet rays is often not straightforward. And public health messaging around when and how to be screened for skin cancer has become somewhat confusing.